- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Trial completion, Trial primary completion date: Rituximab in IgG4-RD: A Phase 1-2 Trial (clinicaltrials.gov) - Jan 8, 2015 P1/2, N=30, Completed, Trial primary completion date: May 2015 --> Oct 2015 Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jan 2014
- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Enrollment closed: Rituximab in IgG4-RD: A Phase 1-2 Trial (clinicaltrials.gov) - Oct 17, 2013 P1/2, N=30, Active, not recruiting, Not yet recruiting --> Recruiting | Trial primary completion date: May 2014 --> May 2015 Recruiting --> Active, not recruiting
|